Evogene Ltd. (EVGN)
NASDAQ·Healthcare·Biotechnology
$0.44
-10.60%
Mkt Cap $6.67M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$2.15
Range $2.15 – $2.15
Implied Upside
+387.3%
Consensus $2.15 vs current $0.44
NASDAQ·Healthcare·Biotechnology
$0.44
-10.60%
Mkt Cap $6.67M
No recent rating data.
Price Target (3 analysts)
$2.15
Range $2.15 – $2.15
+387.3%
Consensus $2.15 vs current $0.44